HAP-1 is a potent inhibitor widely used in biomedicine for cancer research. It targets specific signaling pathways, offering a promising approach for treating various types of cancers, including breast, lung, and prostate. HAP-1's effective suppression of tumor growth makes it a valuable tool for studying cancer progression and exploring potential therapeutic interventions.
CAT# | GR2215 |
CAS | 329004-38-8 |
M.F/Formula | C60H90N18O17 |
M.W/Mr. | 1335.47 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
PBP 10 (RhoB-Glu-Arg-Leu-Phe-Glc-Val-Lys-Glc-Arg-Arg) is a 10-aa-long rhodamine-linked and membrane-permeable pe ...
Leuprolide acetate, an acetate salt with similar structure to luteinizing hormone-releasing hormone (LHRH) secre ...
Appropriate perfusion preservation solution is of great significance for reducing or slowing down various damage ...
NF-кB activator 1, named Act1, is a 60-kDa (574-aa) polypeptide. Based on its interaction with IKKγ, Act1can be ...
The thymopentin is a small peptide consisting of 5 amino acid residues (Arg-Lys-Asp-Val-Tyr) from thymosin. It h ...